The humanoid robotics industry has a new landmark. Unitree Robotics, the Hangzhou-based company that shipped more humanoid robots than any other company in the world last year, has filed for an initial public offering on Shanghai’s STAR Market, seeking to raise 4.2 billion yuan — approximately $610 million. The filing is significant not just for its scale but for what it reveals about the financial reality of building a humanoid robot business.
Most companies in the humanoid robotics space are burning cash rapidly, investing heavily in research and development while generating minimal revenue. Unitree is a striking exception. According to its 363-page prospectus, the company turned profitable in 2025, posting an adjusted net profit of 600 million yuan ($90 million), a 674% increase from the previous year. Revenue surged to 1.71 billion yuan ($250 million) from 392 million yuan ($57 million) in 2024, a 336% increase.
The company sold approximately 5,500 humanoid robots in 2025, accounting for roughly one-third of global humanoid robot sales, according to Rest of World. But humanoids are only part of the story: Unitree has also shipped more than 30,000 quadruped robots, the four-legged, dog-like machines that first brought the company to international attention, since 2022. In 2025, humanoids crossed the 50% threshold of core revenue for the first time, marking a genuine shift in the company’s business mix.
Perhaps the most striking figure in the prospectus is the trajectory of humanoid robot prices. In 2023, the average selling price of a Unitree humanoid was approximately 593,400 yuan ($85,000). By 2025, that figure had fallen to 167,600 yuan ($25,000), a reduction of more than 70% in two years. Elon Musk has suggested that Tesla’s Optimus robots will eventually cost less than a new car, at around $20,000; Unitree is already approaching that price point. What makes the price decline even more remarkable is that it has been accompanied by an improvement in gross margins to nearly 60%, reflecting the company’s strategy of self-developing and manufacturing core components rather than sourcing them from third parties.
The IPO comes at a moment when the global humanoid robotics race is intensifying. Tesla is preparing for retail sales of Optimus by 2027. Boston Dynamics, now majority-owned by Hyundai, is deploying its Atlas robot in industrial settings. In China, Agibot recently announced the rollout of its 10,000th humanoid robot, while a new automated production facility in Foshan, Guangdong, can produce one humanoid every 30 minutes. The competitive landscape is crowded and moving fast.
Unitree’s prospectus is candid about the risks. The company notes “uncertainties surrounding trade policies and geopolitics” affecting the raw materials it imports, which currently make up around 20% of its supply chain. Humanoid robots rely heavily on Nvidia’s chips and systems for their AI processing, a dependency that exposes them to the same export control dynamics that have affected other sectors of China’s technology industry. The company’s five-year plan calls for producing 75,000 humanoid robots and 115,000 quadrupeds annually, a scale-up that will require substantial capital investment and continued technological progress.
The market’s reception of the IPO will be closely watched as a bellwether for the broader humanoid robotics sector. Counterpoint Research’s Ethan Qi told Rest of World that the current cohort of more than 100 humanoid companies in China is likely to consolidate significantly following the first wave of IPOs, with the number of viable players eventually falling to a few dozen. Unitree’s listing, if successful, will establish a valuation benchmark that shapes how the rest of the sector is priced and how much capital flows into it.
For international investors and technology observers, the Unitree prospectus offers the most detailed public financial picture yet of what a scaled humanoid robotics business actually looks like. The conclusion it supports is both encouraging and sobering: it is possible to build a profitable humanoid robot company, but doing so requires extraordinary execution, a relentless focus on cost reduction, and a willingness to operate in a market that is simultaneously supported by government policy and exposed to geopolitical risk.